MedTrace Logo

Sodium Management in Acute and Chronic Heart Failure

NCT01156337 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2011-11-21

No results posted yet for this study

Summary

The study was aimed to verify the effects of Hypertonic saline solution (HSS) and a moderate sodium (Na) restriction plus high furosemide dose in the short term (hospitalization time) and a moderate Na restriction in the long term on readmissions and mortality in patients in III NYHA class.

Conditions

Sponsors & Collaborators

  • University of Palermo

    collaborator OTHER

  • University of Naples

    collaborator OTHER

  • Buccheri La Ferla Hospital, Palermo

    collaborator OTHER

  • Ospedale G. F. Ingrassia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156337 on ClinicalTrials.gov